|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Laskin JJ and Sandler AB: State of the art
in therapy for non-small cell lung cancer. Cancer Invest.
23:427–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma L, Qiu B, Zhang J, Li QW, Wang B, Zhang
XH, Qiang MY, Chen ZL, Guo SP and Liu H: Survival and prognostic
factors of non-small cell lung cancer patients with postoperative
locoregional recurrence treated with radical radiotherapy. Chin J
Cancer. 36:932017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murray N: Reality check for pemetrexed and
maintenance therapy in advanced non-small-cell lung cancer. J Clin
Oncol. 32:482–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferguson MK: Diagnosing and staging of
non-small cell lung cancer. Hematol Oncol Clin North Am.
4:1053–1068. 1990.PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao Y, Shen H, Zhou Y, Yang Z and Hu T:
MicroRNA-215 suppresses the proliferation, migration and invasion
of non-small cell lung carcinoma cells through the downregulation
of matrix metalloproteinase-16 expression. Exp Ther Med.
15:3239–3246. 2018.PubMed/NCBI
|
|
9
|
Wei L and Ran F: MicroRNA-20a promotes
proliferation and invasion by directly targeting early growth
response 2 in non-small cell lung carcinoma. Oncol Lett.
15:271–277. 2018.PubMed/NCBI
|
|
10
|
Pang PC, Shi XY, Huang WL and Sun K:
miR-497 as a potential serum biomarker for the diagnosis and
prognosis of osteosarcoma. Eur Rev Med Pharmacol Sci. 20:3765–3769.
2016.PubMed/NCBI
|
|
11
|
Pengcheng S, Ziqi W, Luyao Y, Xiangwei Z,
Liang L, Yuwei L, Lechen L and Wanhai X: MicroRNA-497 suppresses
renal cell carcinoma by targeting VEGFR-2 in ACHN cells. Biosci
Rep. 37:372017. View Article : Google Scholar
|
|
12
|
Wu R, Tang S, Wang M, Xu X, Yao C and Wang
S: MicroRNA-497 induces apoptosis and suppresses proliferation via
the Bcl-2/Bax-caspase9-caspase3 pathway and cyclin D2 protein in
HUVECs. PLoS One. 11:e01670522016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao L, Zhang CY, Guo L, Li X, Han NN, Zhou
Q and Liu ZL: MicroRNA-497 accelerates apoptosis while inhibiting
proliferation, migration, and invasion through negative regulation
of the MAPK/ERK signaling pathway via RAF-1. J Cell Physiol.
233:6578–6588. 2017. View Article : Google Scholar
|
|
14
|
Hu J, Xu JF and Ge WL: MiR-497 enhances
metastasis of oral squamous cell carcinoma through SMAD7
suppression. Am J Transl Res. 8:3023–3031. 2016.PubMed/NCBI
|
|
15
|
Song KH, Cho H, Kim S, Lee HJ, Oh SJ, Woo
SR, Hong SO, Jang HS, Noh KH, Choi CH, et al: API5 confers cancer
stem cell-like properties through the FGF2-NANOG axis. Oncogenesis.
6:e2852017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khurana A, Liu P, Mellone P, Lorenzon L,
Vincenzi B, Datta K, Yang B, Linhardt RJ, Lingle W, Chien J, et al:
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion
of breast cancer cells. Cancer Res. 71:2152–2161. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coleman SJ, Chioni AM, Ghallab M, Anderson
RK, Lemoine NR, Kocher HM and Grose RP: Nuclear translocation of
FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic
cancer cell invasion. EMBO Mol Med. 6:467–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joy A, Moffett J, Neary K, Mordechai E,
Stachowiak EK, Coons S, Rankin-Shapiro J, Florkiewicz RZ and
Stachowiak MK: Nuclear accumulation of FGF-2 is associated with
proliferation of human astrocytes and glioma cells. Oncogene.
14:171–183. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sooman L, Freyhult E, Jaiswal A, Navani S,
Edqvist PH, Pontén F, Tchougounova E, Smits A, Elsir T, Gullbo J,
et al: FGF2 as a potential prognostic biomarker for proneural
glioma patients. Acta Oncol. 54:385–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xue G, Yan HL, Zhang Y, Hao LQ, Zhu XT,
Mei Q and Sun SH: c-Myc-mediated repression of miR-15-16 in hypoxia
is induced by increased HIF-2α and promotes tumor angiogenesis and
metastasis by upregulating FGF2. Oncogene. 34:1393–1406. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang CL, Zheng XL, Ye K, Ge H, Sun YN, Lu
YF and Fan QX: MicroRNA-183 acts as a tumor suppressor in human
non-small cell lung cancer by down-regulating MTA1. Cell Physiol
Biochem. 46:93–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu M, Zhang Y, Zhang J, Cai H, Zhang C,
Yang Z, Niu Y, Wang H, Wei X, Wang W, et al: MicroRNA-1253
suppresses cell proliferation and invasion of non-small-cell lung
carcinoma by targeting WNT5A. Cell Death Dis. 9:1892018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Wang Y, Sun D, Bu J, Ren F, Liu B,
Zhang S, Xu Z, Pang S and Xu S: miR-455-5p promotes cell growth and
invasion by targeting SOCO3 in non-small cell lung cancer.
Oncotarget. 8:114956–114965. 2017.PubMed/NCBI
|
|
25
|
Huang C, Ma R, Yue J, Li N, Li Z and Qi D:
MiR-497 suppresses YAP1 and inhibits tumor growth in non-small cell
lung cancer. Cell Physiol Biochem. 37:342–352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Z, Li A, Yu Z, Li X, Guo X and Chen R:
MicroRNA-497-5p suppresses tumor cell growth of osteosarcoma by
targeting ADP ribosylation factor-like protein 2. Cancer Biother
Radiopharm. 32:371–378. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang P, Meng X, Huang Y, Lv Z, Liu J, Wang
G, Meng W, Xue S, Zhang Q, Zhang P, et al: MicroRNA-497 inhibits
thyroid cancer tumor growth and invasion by suppressing BDNF.
Oncotarget. 8:2825–2834. 2017.PubMed/NCBI
|
|
28
|
Xu Y, Chen J, Gao C, Zhu D, Xu X, Wu C and
Jiang J: MicroRNA-497 inhibits tumor growth through targeting
insulin receptor substrate 1 in colorectal cancer. Oncol Lett.
14:6379–6386. 2017.PubMed/NCBI
|
|
29
|
Li J, Zhang Y, Wang X and Zhao R:
microRNA-497 overexpression decreases proliferation, migration and
invasion of human retinoblastoma cells via targeting vascular
endothelial growth factor A. Oncol Lett. 13:5021–5027. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Yu Z, Xian Y and Lin X:
microRNA-497 inhibits cell proliferation and induces apoptosis by
targeting YAP1 in human hepatocellular carcinoma. FEBS Open Bio.
6:155–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ruan WD, Wang P, Feng S, Xue Y and Zhang
B: MicroRNA-497 inhibits cell proliferation, migration, and
invasion by targeting AMOT in human osteosarcoma cells. Onco
9Targets Ther. 9:303–313. 2016. View Article : Google Scholar
|
|
32
|
Cheng Z, Ma R, Tan W and Zhang L: MiR-152
suppresses the proliferation and invasion of NSCLC cells by
inhibiting FGF2. Exp Mol Med. 46:e1122014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Xu J, Jiang T, Liu G, Wang D and
Lu Y: MicroRNA-195 suppresses colorectal cancer cells proliferation
via targeting FGF2 and regulating Wnt/β-catenin pathway. Am J
Cancer Res. 6:2631–2640. 2016.PubMed/NCBI
|
|
34
|
Hu Y, Qiu Y, Yagüe E, Ji W, Liu J and
Zhang J: miRNA-205 targets VEGFA and FGF2 and regulates resistance
to chemotherapeutics in breast cancer. Cell Death Dis. 7:e22912016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun XH, Geng XL, Zhang J and Zhang C:
miRNA-646 suppresses osteosarcoma cell metastasis by downregulating
fibroblast growth factor 2 (FGF2). Tumour Biol. 36:2127–2134. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He Q, Ren X, Chen J, Li Y, Tang X, Wen X,
Yang X, Zhang J, Wang Y, Ma J, et al: miR-16 targets fibroblast
growth factor 2 to inhibit NPC cell proliferation and invasion via
PI3K/AKT and MAPK signaling pathways. Oncotarget. 7:3047–3058.
2016.PubMed/NCBI
|
